Using a Bionic Pancreas to Manage Diabetes During Pregnancy
Clinical Studies Investigating Use of the Bionic Pancreas in Pregnancy
This study is looking at how the iLet Bionic Pancreas can help pregnant people with type 1 and type 2 diabetes manage their blood sugar better, making their pregnancy safer and healthier.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10975177 on NIH RePORTER |
What this research studies
This research investigates the use of the iLet Bionic Pancreas, an automated insulin delivery system, to improve blood sugar control in pregnant individuals with type 1 and type 2 diabetes. The study aims to address the challenges of maintaining safe blood glucose levels during pregnancy, which can be particularly difficult due to hormonal changes and the risk of hypoglycemia. By including pregnant individuals in clinical trials, the research seeks to evaluate how this technology can enhance glycemic management and reduce complications associated with diabetes in pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant individuals diagnosed with type 1 or type 2 diabetes who are seeking improved management of their blood glucose levels.
Not a fit: Patients without diabetes or those who are not pregnant may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve pregnancy outcomes for individuals with diabetes by providing better blood sugar control and reducing the risk of complications.
How similar studies have performed: Previous studies have shown promising results with automated insulin delivery systems in non-pregnant populations, but this research is novel in its focus on pregnant individuals.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Powe, Camille Elise — Massachusetts General Hospital
- Study coordinator: Powe, Camille Elise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.